Julien Meissonnier

Vice President Science & Technology

Catalent Pharma Solutions

Julien Meissonnier was appointed Catalent’s Vice President, Science and Technology in 2015. In this role Mr. Meissonnier leads a dedicated global team of drug development and technology experts.

Julien Meissonnier B&W

At any one time, Catalent is working on more than 500 new development projects and contributes to nearly 200 new product launches annually. Mr. Meissonnier had previously led Catalent’s European softgel R&D team, focused on early stage screening activities, developing products including OptiShell™ capsules and OptiGel™ Bio capsules, scale-up and technology transfer, directing clinical supplies, and supporting product launches. He holds an Engineering degree in Physico-Chemistry from the ENSI in Caen, France.